MedPath

A multicenter observational study using multigene assays to assess the risk of early recurrence in hormone receptor-positive, HER2-negative early breast cancer(WJOG16722B)

Not Applicable
Recruiting
Conditions
Hormone receptor positive and HER2 negative early breast cancer
Registration Number
JPRN-UMIN000050930
Lead Sponsor
West Japan Oncology Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath